Jpmorgan Chase & CO Selecta Biosciences Inc Transaction History

Jpmorgan Chase & CO

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Dec 26, 2024	BUY	$0.62 - $0.85 $883,595 - $1.21 Million	1,425,154 New	1,425,154 $1.2 Million
Q1 2024 May 10, 2024	SELL	$0.62 - $0.85 $34,506 - $47,307	-55,656 Reduced 3.76%	1,425,154 $1.2 Million
Q4 2023 Dec 26, 2024	BUY	$0.67 - $1.35 $992,142 - $2 Million	1,480,810 New	1,480,810 $1.02 Million
Q4 2023 Feb 12, 2024	SELL	$0.67 - $1.35 $13,546 - $27,295	-20,219 Reduced 1.35%	1,480,810 $1.02 Million
Q3 2023 Nov 14, 2023	SELL	$1.02 - $1.23 $556,731 - $671,352	-545,815 Reduced 26.67%	1,501,029 $1.59 Million
Q2 2023 Aug 11, 2023	BUY	$1.04 - $1.4 $52,782 - $71,052	50,752 Added 2.54%	2,046,844 $2.29 Million
Q1 2023 May 11, 2023	SELL	$1.15 - $1.89 $29,136 - $47,885	-25,336 Reduced 1.25%	1,996,092 $2.77 Million
Q4 2022 Feb 13, 2023	SELL	$0.96 - $1.6 $5,747 - $9,579	-5,987 Reduced 0.3%	2,021,428 $2.29 Million
Q3 2022 Nov 14, 2022	BUY	$1.33 - $2.6 $469,231 - $917,295	352,806 Added 21.07%	2,027,415 $3.32 Million
Q2 2022 Aug 11, 2022	BUY	$0.67 - $1.4 $297,020 - $620,639	443,314 Added 36.0%	1,674,609 $2.19 Million
Q1 2022 May 11, 2022	SELL	$1.23 - $3.31 $106,291 - $286,036	-86,416 Reduced 6.56%	1,231,295 $1.51 Million
Q4 2021 Feb 10, 2022	SELL	$2.89 - $4.43 $1.55 Million - $2.37 Million	-535,790 Reduced 28.91%	1,317,711 $4.3 Million
Q3 2021 Nov 12, 2021	BUY	$3.36 - $4.62 $6.23 Million - $8.56 Million	1,853,501 New	1,853,501 $7.71 Million

4.67M

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.